Floatz logo

Marijuana

Glioblastoma

New York State Psychiatric InstitutePhase 1Dormant
C
37/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
65/ 100

Competitive context

234 Active assets in the Glioblastoma cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
University of Cincinnati
Phase 3BB
Enzastaurin
Denovo Biopharma LLC
Phase 3BB
Inno-206
Université de Sherbrooke
Phase 2BB
ETOPOSIDE
Sichuan Honghe Biotechnology Co., Ltd.
Phase 2/3BB
Paxalisib
Institute of Cancer Research, United Kingdom
Phase 2/3B

View all 50 →

Same molecule, other indications

Marijuana is also rated in:

CannabisDormant
BB
Indicative ·
71 / 100
View asset →
HIV NeuropathyDormant
BB
Indicative ·
65 / 100
View asset →
Diabetic Peripheral Neuropathic PainDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →